0,902  0,004  Antileukemic
0,867  0,004  Antipsoriatic
0,648  0,028  Antineoplastic (breast cancer)
0,632  0,043  Apoptosis agonist
0,597  0,025  TNF expression inhibitor
0,545  0,006  P-glycoprotein inhibitor
0,570  0,035  Transcription factor NF kappa B inhibitor
0,503  0,008  Antiulcerative
0,559  0,065  Antiinflammatory
0,495  0,005  Antiacne
0,499  0,012  ICAM1 expression inhibitor
0,498  0,016  Nitric oxide antagonist
0,506  0,031  Antipruritic, allergic
0,495  0,021  AR expression inhibitor
0,448  0,005  Acaricide
0,485  0,066  Caspase 9 stimulant
0,444  0,027  Sensitization
0,448  0,032  FMO1 substrate
0,444  0,030  Antineoplastic (cervical cancer)
0,425  0,026  Antiprotozoal (Leishmania)
0,446  0,055  Antineoplastic (lung cancer)
0,419  0,029  NOS2 expression inhibitor
0,413  0,024  Interleukin 2 agonist
0,424  0,055  Immunosuppressant
0,400  0,044  Respiratory analeptic
0,375  0,032  Tumour necrosis factor alpha release inhibitor
0,393  0,053  Prostate cancer treatment
0,417  0,086  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,364  0,035  Hypoglycemic
0,347  0,020  Skin irritative effect
0,354  0,034  Hypolipemic
0,383  0,064  Thioredoxin glutathione reductase inhibitor
0,350  0,040  Sodium/bile acid cotransporter inhibitor
0,344  0,040  Cardiovascular analeptic
0,312  0,010  Interleukin 1 antagonist
0,358  0,058  Antifungal
0,374  0,077  GST A substrate
0,347  0,053  Antineoplastic (brain cancer)
0,341  0,049  Antioxidant
0,331  0,039  Mutagenic
0,307  0,019  Interferon gamma antagonist
0,314  0,027  Tyrosine 3 hydroxylase inhibitor
0,304  0,028  Eye irritation, high
0,331  0,058  Lipoprotein disorders treatment
0,331  0,058  Analeptic
0,308  0,041  Chemopreventive
0,311  0,045  Interleukin antagonist
0,340  0,082  CYP3A4 substrate
0,271  0,022  Protein kinase stimulant
0,307  0,060  Antihypercholesterolemic
0,299  0,058  Antineoplastic (glioma)
0,306  0,068  CTGF expression inhibitor
0,307  0,074  Antimycobacterial
0,283  0,052  Antineoplastic (glioblastoma multiforme)
0,243  0,013  Interleukin 1b antagonist
0,267  0,038  VCAM1 expression inhibitor
0,277  0,051  Gastrin inhibitor
0,290  0,070  Antituberculosic
0,284  0,069  UGT2B4 substrate
0,218  0,002  Retinoic acid receptor agonist
0,274  0,059  Free radical scavenger
0,215  0,004  Thioredoxin reductase inhibitor
0,273  0,063  Proliferative diseases treatment
0,219  0,011  Growth stimulant
0,259  0,053  Carcinogenic
0,283  0,083  NOS3 expression inhibitor
0,317  0,123  Antibacterial
0,216  0,024  Antirickettsial
0,222  0,033  Lipid peroxidase inhibitor
0,235  0,048  UGT2B7 substrate
0,256  0,069  Antineoplastic (liver cancer)
0,321  0,142  5 Hydroxytryptamine release inhibitor
0,252  0,077  Interleukin agonist
0,204  0,029  Arachidonic acid antagonist
0,216  0,044  Antihelmintic (Nematodes)
0,173  0,003  Retinoic acid alpha receptor agonist
0,203  0,035  UGT2B10 substrate
0,233  0,067  Cytotoxic
0,253  0,088  5 Hydroxytryptamine release stimulant
0,201  0,037  Carcinogenic, group 3
0,255  0,091  GST M1-1 substrate
0,168  0,005  Transcription factor AP-1 inhibitor
0,286  0,125  GABA C receptor rho-3 antagonist
0,171  0,012  Ca2+-transporting ATPase inhibitor
0,211  0,054  Antipruritic, non-allergic
0,220  0,064  Anesthetic general
0,234  0,078  Embryotoxic
0,157  0,003  Retinoic acid beta receptor agonist
0,247  0,096  Antineoplastic (colon cancer)
0,166  0,016  Actinic keratosis treatment
0,240  0,091  5 Hydroxytryptamine uptake stimulant
0,251  0,102  Antineoplastic (colorectal cancer)
0,230  0,082  Teratogen
0,212  0,064  Pneumotoxic
0,173  0,026  Antineoplastic antibiotic
0,167  0,025  Vanilloid 1 agonist
0,188  0,046  UGT2B9 substrate
0,194  0,053  Succinate dehydrogenase inhibitor
0,252  0,112  Bone diseases treatment
0,227  0,089  Antineoplastic (non-small cell lung cancer)
0,193  0,057  Tumour necrosis factor antagonist
0,235  0,101  Antineoplastic (melanoma)
0,158  0,026  TRPA1 agonist
0,242  0,110  FMO3 substrate
0,147  0,018  ABCA1 expression enhancer
0,180  0,051  UGT2B15 substrate
0,201  0,072  Sedative
0,230  0,101  Transcription factor STAT3 inhibitor
0,156  0,029  Papain-like protease (SARS coronavirus) inhibitor
0,145  0,017  Inducible nitric-oxide synthase inhibitor
0,156  0,030  Alcohol dehydrogenase substrate
0,169  0,045  Skin whitener
0,140  0,017  Macrophage colony-stimulating factor 1 receptor antagonist
0,175  0,055  Melanin inhibitor
0,127  0,011  Antiviral (Hepatitis A)
0,202  0,086  Antiparkinsonian, rigidity relieving
0,152  0,036  Microtubule formation inhibitor
0,224  0,110  CYP2C19 substrate
0,161  0,047  Adenylate cyclase stimulant
0,132  0,018  Ornithine decarboxylase inhibitor
0,188  0,076  Wound healing agent
0,155  0,044  Aldehyde dehydrogenase inhibitor
0,210  0,103  Antineoplastic (renal cancer)
0,220  0,112  Chemoprotective
0,212  0,105  DNA synthesis inhibitor
0,161  0,055  SULT1A3 substrate
0,108  0,003  Retinoic acid alpha receptor antagonist
0,122  0,018  ATPase (Vacuolar H+) inhibitor
0,170  0,066  Antimutagenic
0,131  0,028  Androgen antagonist
0,101  0,003  Retinoic acid receptor antagonist
0,223  0,125  CYP1A2 substrate
0,183  0,085  Abortion inducer
0,162  0,065  Carcinogenic, group 1
0,211  0,114  Antineoplastic (ovarian cancer)
0,126  0,029  UGT2B11 substrate
0,184  0,093  Neurotrophic factor enhancer
0,126  0,037  Interleukin 2 antagonist
0,244  0,155  CYP2C9 substrate
0,178  0,089  Non-steroidal antiinflammatory agent
0,172  0,087  Hepatoprotectant
0,086  0,003  Retinoic acid beta receptor antagonist
0,121  0,038  GST T1-1 substrate
0,128  0,045  Aldehyde dehydrogenase substrate
0,121  0,039  Anabolic
0,181  0,101  Antiparasitic
0,140  0,061  Alpha-N-acetylglucosaminidase inhibitor
0,081  0,003  Retinoic acid receptor gamma antagonist
0,080  0,003  Retinoic acid gamma receptor agonist
0,127  0,050  Carcinogenic, group 2B
0,150  0,074  Phospholipase A2 inhibitor
0,091  0,016  Antimycoplasmal
0,079  0,004  Cyclophilin A inhibitor
0,202  0,127  Flavin-containing monooxygenase substrate
0,118  0,044  Gastric antisecretory
0,175  0,101  Insulin sensitizer
0,155  0,083  UGT1A4 substrate
0,078  0,008  Retinoid X receptor agonist
0,169  0,098  UGT1A1 substrate
0,138  0,068  Antifungal enhancer
0,128  0,058  Contraceptive female
0,113  0,043  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,158  0,088  ATPase inhibitor
0,207  0,139  Antihypoxic
0,202  0,135  Transcription factor STAT inhibitor
0,138  0,071  Contraceptive
0,126  0,060  Cholesterol synthesis inhibitor
0,120  0,054  Ferrochelatase inhibitor
0,186  0,123  RNA-directed DNA polymerase inhibitor
0,201  0,139  Lipoxygenase inhibitor
0,213  0,151  Caspase 3 stimulant
0,159  0,098  LDLR expression enhancer
0,136  0,075  Antineoplastic (squamous cell carcinoma)
0,095  0,034  Keratolytic
0,177  0,117  Antiviral (HIV)
0,123  0,063  Proteasome inhibitor
0,093  0,033  GABA aminotransferase inhibitor
0,176  0,117  Antineoplastic (lymphoma)
0,108  0,049  Nitric-oxide synthase inhibitor
0,194  0,136  UGT1A9 substrate
0,063  0,005  Retinoid X receptor antagonist
0,062  0,005  Retinoid X gamma receptor agonist
0,070  0,017  Dihydroorotate oxidase inhibitor
0,172  0,118  Antineoplastic enhancer
0,196  0,144  Radiosensitizer
0,055  0,005  Retinoid X alpha receptor antagonist
0,079  0,028  Protease 3C (Human rhinovirus) inhibitor
0,121  0,073  Coagulant
0,059  0,011  Retinoid X alpha receptor agonist
0,052  0,005  Retinoid X beta receptor agonist
0,091  0,045  Vanilloid agonist
0,066  0,019  Pregnane X receptor antagonist
0,155  0,108  UDP-glucuronosyltransferase substrate
0,068  0,023  Postcoital contraceptive
0,239  0,195  Transcription factor inhibitor
0,180  0,136  Antihypotensive
0,104  0,062  GABA C receptor agonist
0,218  0,177  Ulceration
0,152  0,112  Phobic disorders treatment
0,180  0,141  Superoxide dismutase inhibitor
0,068  0,029  Heme oxygenase stimulant
0,042  0,004  Retinoid X gamma receptor antagonist
0,073  0,036  Exportin-1 inhibitor
0,185  0,149  Neuropeptide Y2 antagonist
0,140  0,105  Antiviral (Hepatitis C)
0,066  0,031  Human rhinovirus A protease inhibitor
0,065  0,030  Acyl-CoA dehydrogenase inhibitor
0,089  0,054  Carcinogenic, group 2A
0,139  0,105  Liver fibrosis treatment
0,090  0,058  Antidote, mercury
0,105  0,073  SULT1A1 substrate
0,057  0,026  Anesthetic inhalation
0,169  0,139  5 Hydroxytryptamine 3E antagonist
0,033  0,004  Retinoid X beta receptor antagonist
0,030  0,005  Progesterone receptor B antagonist
0,065  0,041  Transcription factor RelA inhibitor
0,093  0,069  UDP-glucose 4-epimerase inhibitor
0,176  0,152  Antineoplastic (pancreatic cancer)
0,140  0,116  DNA methyltransferase I inhibitor
0,215  0,191  Calcium channel activator
0,075  0,053  CYP2A6 inhibitor
0,049  0,027  Adenylate cyclase 1 inhibitor
0,082  0,060  Estrogen-related receptor beta agonist
0,044  0,022  Kainate receptor agonist
0,042  0,020  Potassium channel Kv1.1 blocker
0,124  0,103  Genotoxic
0,114  0,094  Interleukin 4 antagonist
0,141  0,121  Antihelmintic
0,049  0,030  Potassium channel Kv1.3 blocker
0,021  0,003  Immunosuppressant Cyclosporine-like
0,187  0,169  Hypoxia-inducible factor 1 alpha inhibitor
0,111  0,097  Antiviral (Papilloma)
0,066  0,052  Andropause treatment
0,138  0,125  3C-like protease (Human coronavirus) inhibitor
0,107  0,095  Cathepsin H inhibitor
0,083  0,073  HIV-1 integrase (Overall Integration) inhibitor
0,066  0,056  SULT2A1 substrate
0,068  0,059  Glycine receptor agonist
0,121  0,113  UGT1A3 substrate
0,075  0,067  Antidote, organophosphates
0,067  0,062  Na+ K+ transporting ATPase inhibitor
0,079  0,074  Antileprosy
0,184  0,180  Cholesterol antagonist
0,149  0,145  Antineoplastic (lymphocytic leukemia)
0,154  0,151  UGT1A6 substrate
0,054  0,051  Lipocortins synthesis agonist
0,036  0,033  Membrane dipeptidase inhibitor
0,078  0,075  Transcription factor NF kappa B stimulant
0,081  0,079  5-Lipoxygenase inhibitor
0,009  0,007  Progesterone receptor A antagonist
0,157  0,157  Spasmolytic
0,108  0,108  Hair growth stimulant

